Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Large ribosomal subunit protein mL54, mitochondrial (MRPL54), is a protein component of the mammalian mitochondrial large ribosomal 39S subunit, essential for mitochondrial translation. MRPL54 is encoded by a nuclear gene, translated in the cytosol, and imported into mitochondria, where it integrates into the mitochondrial ribosome as part of the machinery that synthesizes mitochondrial-encoded membrane proteins necessary for oxidative phosphorylation[4][6]. MRPL54 is required for proper mitochondrial ribosomal assembly and function, and by extension, for efficient expression of the mitochondrial genome and maintenance of mitochondrial energy metabolism[2][4][6]. Loss of MRPL54 impairs mitochondrial protein synthesis and is embryonically lethal in homozygous mice[2]. Mitochondrial ribosomal proteins like MRPL54 are structurally and functionally distinct from their bacterial and cytoplasmic counterparts, playing specialized roles in mitochondrial translation and cellular energy balance[1][3]. While the family of mitochondrial ribosomal proteins has been proposed as a conceptual target space for diseases involving mitochondrial dysfunction, including cancer[1], MRPL54 itself is not a direct therapeutic target, and there are no known drugs that act on it specifically. Reduced expression of MRPL54 can lower mitochondrial-encoded protein content; however, partial reduction in mice does not significantly alter metabolic health or lifespan in unstressed states[2].
Not applicable (no known drugs targeting MRPL54 directly; its biological mechanism is as a structural component of the mitochondrial ribosome, essential for mitochondrial protein synthesis[4][6])
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Large ribosomal subunit protein mL54, mitochondrial (MRPL54).